➕ Reduce bloating
➕ Improve nutrition
➕ Simplify visits
FODZYME®‘s enzyme blend breaks down FODMAPs before they can cause symptoms, supporting nutritional diversity, dietary flexibility, symptom relief and enhanced quality of life for patients.*

FODZYME®‘s enzyme blend breaks down FODMAPs before they can cause symptoms, supporting nutritional diversity, dietary flexibility, symptom relief and enhanced quality of life for patients.*


10,000+
Providers recommend FODZYME®
90%
of 3g fructan broken down within 30 min*1
78%
Report decreased bloating after 4 weeks*2

Your patients have tried everything to find relief —
elimination diets, complex protocols, remedies from online influencers. Controlling common digestive issues shouldn’t be this complex, or restrictive.
With FODZYME®, offer your patients an easy, simple way to manage bloating, gas, abdominal discomfort, diarrhea and constipation. No dietary change required.*


** FODZYME® significantly reduces fructan (a FODMAP) in wheat, barley and rye products, not gluten. Fructan is often the real trigger in individuals with non-celiac gluten sensitivity.
FODZYME®'s unique blend features a novel fructan hydrolase, plus alpha-galactosidase and lactase. Fructan hydrolase is our proprietary enzyme, and the only one shown to break down a variety of fructans, the most common FODMAP trigger in IBS.
FODZYME® digestive enzymes start working on the FODMAPs they target as soon as they are added and throughout the digestive process. This is highly effective due to its powdered form.
.png)
FODMAP substrate: Fructans including fructo-oligosaccharides (FOS) and inulin
Common foods: Artichoke, asparagus, bread, Brussels sprouts, garlic, leek, onion, shallot, wheat products

FODMAP substrate: Galacto-oligosaccharides (GOS/galactans)
Common foods: Beans, beets, cashews, chickpeas, hummus, lentils, pistachio, silken tofu, soybeans

FODMAP substrate: Lactose
Common foods: Cottage cheese, buttermilk, ice cream, kefir, milk, ricotta, soft cheese, yogurt
In development are additional enzymes to address polyols, like mannitol and sorbitol, found in foods such as apple, celery, mushroom and stone fruits.

A brief overview on how FODZYME® works to break down FODMAPs, the research behind the enzyme blend and which patients benefit

A summary on the research literature supporting use of FODMAP-targeting digestive enzymes, such as a FODZYME®, for IBS
With a team of experts in medicine, nutrition, and biotechnology, we have developed proprietary digestive enzymes. FODZYME®’s novel fructan hydrolase is the only enzyme available that can break down fructans, the most common FODMAP trigger in IBS.

-1.png?width=300&height=300&name=Pexels%20Photo%20by%20Estudio%20Polaroid%20(1)-1.png)
Gastroenterologists ● Registered Dietitians ● Nurses ● Primary Care Physicians ● Physician Assistants
"Not only do I suggest FODZYME® as a tool for my clients to boost food variety and reduce 'FODMAP Fatigue.' I also use it to manage my own digestive distress to enjoy the foods I love!"
"For my patients struggling with fodmap sensitivities, especially to fructans, GOS and lactose, FODZYME® has been a god-send.
Anecdotally, patients have described being about to eat outside the home with significantly more ease and enjoyment, and has allowed some to start cooking with onion and garlic again."
"The best compliment I get from my patients is when they finally have freedom to eat what they love. With FODZYME®, my patients have been enjoying high-fiber meals that are painless and make them feel good.”
%202-2-1.png)
Help your patients try FODZYME® risk-free with free samples, discounts and educational resources.
Reduce the need for restrictive diets, complex grocery lists and special meal requests.
Your patients will thank you!
%202-2-2.png)
1. Kenny Castro Ochoa, Samant S, Liu A, et al. In Vitro Efficacy of Targeted Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Enzymatic Digestion in a High-Fidelity Simulated Gastrointestinal Environment. Gastro Hep Advances. 2022;2(3):283-290. doi:https://doi.org/10.1016/j.gastha.2022.10.011. (This study was funded by Kiwi Biosciences.)
2. Kaye AJ. Fodzyme at Its Finest: A Case Series Exploring a New Option for IBS Patients. Presented at: The American College of Gastroenterology; October 2024; Philadelphia, PA. Poster P4059. (This study was funded by Kiwi Biosciences.)